Search

everythinglearnresearchcommunity

for

Search:↓

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Alefacept does not effectively treat severe alopecia areata.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

RCS-01 cell therapy is safe and improves skin gene expression.

A patient with a severe scalp burn developed chronic bone infection, treated with surgery and muscle-skin flap from the back.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Applying InlB321/15 to wounds sped up healing in mice.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

A 93-year-old woman developed a rare scalp condition after therapy, which improved with steroids, not antibiotics.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Stem cell therapy may help treat tough hair loss cases.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.